Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Q368STOP myocilin mutation in a population-based cohort: the Blue Mountains Eye Study.

American journal of ophthalmology - 1 Jun 2005

Baird Paul N, Richardson Andrea J, Craig Jamie E, Rochtchina Elena, Mackey David A, Mitchell Paul

Abstract excerpt

PURPOSE: To investigate the prevalence of the Q368STOP myocilin mutation in a population-based cohort: the Blue Mountains Eye Study (BMES). DESIGN: Population-based study. METHODS: DNA was extracted from 2,142 individuals collected through the BMES, including 31 individuals with glaucoma. All individuals were screened for the presence of the Q368STOP mutation of myocilin. Genotyping of the microsatellite markers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon, Terminator
Share to Cytoskeletal Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eye Proteins

Share to Genetics, Population

Share to Glaucoma, Open-Angle

Share to Glycoproteins

Share to New South Wales

Share to Prevalence

Source

Identifiers

PMID: 15953455
DOI: 10.1016/j.ajo.2004.11.061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Q368STOP myocilin mutation in a population-based cohort: the Blue Mountains Eye Study.PMID 15953455Read ↗

Higher prevalence of myocilin mutations in advanced glaucoma in comparison with less advanced disease in an Australasian disease registry.Semantic proximity Read ↗

Analysis of 15 primary open-angle glaucoma families from Australia identifies a founder effect for the Q368STOP mutation of myocilin.Semantic proximity Read ↗

A common disease haplotype for the Q368STOP mutation of the myocilin gene in Australian and Canadian glaucoma families.Semantic proximity Read ↗

Low prevalence of myocilin mutations in an African American population with primary open-angle glaucoma.Semantic proximity Read ↗

Myocilin Gene Gln368Ter Variant Penetrance and Association With Glaucoma in Population-Based and Registry-Based StudiesSemantic proximity Read ↗

Evaluation of the Myocilin Mutation Gln368Stop Demonstrates Reduced Penetrance for Glaucoma in European Populations.Semantic proximity Read ↗

A myocilin Gln368STOP homozygote does not exhibit a more severe glaucoma phenotype than heterozygous cases.Semantic proximity Read ↗

Clinical features associated with an Asp380His Myocilin mutation in a US family with primary open-angle glaucoma.Semantic proximity Read ↗

Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank.Semantic proximity Read ↗

Myocilin gene mutations: A cause of juvenile open-angle glaucoma in north IndiaSemantic proximity Read ↗

Compound heterozygote myocilin mutations in a pedigree with high prevalence of primary open-angle glaucoma.Semantic proximity Read ↗

Variable clinical spectrum of the myocilin Gln368X mutation in a Dutch family with primary open angle glaucoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.